About
Drug Delivery System
Areas of Focus
Categories
Drug Delivery DeviceBoston & New England
Clinical Trials (13)
View allTotal Trials
13
As Lead Sponsor
11
As Collaborator
2
Total Enrollment
695
By Phase
PHASE1: 7PHASE2: 6
By Status
COMPLETED: 12TERMINATED: 1
Clinical Trials Pipeline13 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
Today
Hover over trial bars to see details
Recent Trials
NCT03892499Lead Sponsor
A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers
PHASE1Completed
24 participants
Started: May 3, 2019 · Completed: Jul 3, 2019
NCT03818295Lead Sponsor
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers
PHASE1Completed
8 participants
Started: Mar 1, 2019 · Completed: Apr 24, 2019
NCT03795519Lead Sponsor
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers
PHASE1Completed
8 participants
Started: Jan 17, 2019 · Completed: Feb 27, 2019
NCT03499106Lead Sponsor
A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of Praliciguat (IW-1973) in Healthy Volunteers
PHASE1Completed
24 participants
Started: Apr 12, 2018 · Completed: Jul 6, 2018
NCT03285178Lead Sponsor
A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
PHASE2Completed
88 participants
Started: Dec 22, 2017 · Completed: Jul 22, 2020
Locations (1)
Headquarters
Cambridge, MA, United States
Map
Loading map...